SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
PHASE2
Cohort A and B: This cohort aims to evaluate the efficacy and safety of SHR...
Status
Active Not Recruiting
Location
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
PHASE2
To evaluate the efficacy and safety of Chemotherapy With XELOX (Oxaliplatin...
Status
Recruiting
Location
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial
PHASE2
his is a single-arm, phase II clinical study evaluating the efficacy and sa...